相关实验视频
Updated: May 10, 2025

12:19
Three-Dimensional 3D Tumor Spheroid Invasion Assay
Published on: May 1, 2015
57.0K
瘤亚克隆形成的进展以及生长和入侵的机制
Yuhong Zhang1,2, Weidong Wang3,4
1Department of Oncology, Clinical Medical College, Southwest Medical University, No. 319, Section 3, Zhongshan Road, Luzhou, 646099, Sichuan, China.
Journal of translational medicine
|April 21, 2025
概括
瘤亚克隆,瘤内的独特细胞群,驱动异质性和治疗耐药性. 了解它们的演变和机制是推动精确瘤学和癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 瘤亚克隆是瘤内的独特细胞群,具有独特的遗传特征.
- 它们对于理解瘤异质性,进化和对治疗的耐药性至关重要.
- 驱动子克隆形成的机制包括遗传不稳定性,微环境选择性压力和表观遗传修饰.
研究的目的:
- 提供瘤亚克隆形成机制和进化模型的全面概述.
- 详细介绍研究瘤亚克隆及其临床影响的方法.
- 突出瘤亚克隆在精密瘤学和未来癌症研究中的作用.
主要方法:
- 单细胞测序用于详细的克隆架构分析.
- 液体活检用于对瘤演变的非侵入性监测.
- 空间转录学,以了解子克隆本地化和相互作用.
主要成果:
- 瘤亚克隆对瘤异质性,免疫逃避和治疗耐药性有显著的贡献.
- 研究子克隆有助于指导个性化治疗和预测复发风险.
- 先进的分析方法和多组学对深入的亚克隆调查至关重要.
结论:
- 了解瘤亚克隆对于克服耐药性和开发新型癌症治疗是必不可少的.
- 对瘤亚克隆的研究为精密瘤学提供了关键的见解.
- 整合人工智能和大数据的未来研究将推动癌症诊断和治疗策略.
相关概念视频
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K

